Cerebellum GP LLC Takes Position in Platform Specialty Products Corp (NYSE:PAH)

Cerebellum GP LLC bought a new stake in Platform Specialty Products Corp (NYSE:PAH) in the 1st quarter, according to its most recent 13F filing with the SEC. The firm bought 29,421 shares of the specialty chemicals company’s stock, valued at approximately $297,000.

Several other institutional investors and hedge funds have also recently modified their holdings of PAH. Rhumbline Advisers grew its position in Platform Specialty Products by 6.2% during the 4th quarter. Rhumbline Advisers now owns 213,567 shares of the specialty chemicals company’s stock worth $2,206,000 after purchasing an additional 12,486 shares during the last quarter. Comerica Bank boosted its holdings in shares of Platform Specialty Products by 40.9% in the 4th quarter. Comerica Bank now owns 550,282 shares of the specialty chemicals company’s stock valued at $6,026,000 after acquiring an additional 159,627 shares during the last quarter. BlackRock Inc. boosted its holdings in shares of Platform Specialty Products by 3.7% in the 4th quarter. BlackRock Inc. now owns 16,554,673 shares of the specialty chemicals company’s stock valued at $171,010,000 after acquiring an additional 584,172 shares during the last quarter. Bank of New York Mellon Corp boosted its holdings in shares of Platform Specialty Products by 1.7% in the 4th quarter. Bank of New York Mellon Corp now owns 728,046 shares of the specialty chemicals company’s stock valued at $7,521,000 after acquiring an additional 12,192 shares during the last quarter. Finally, Royce & Associates LP boosted its holdings in shares of Platform Specialty Products by 54.1% in the 4th quarter. Royce & Associates LP now owns 2,111,954 shares of the specialty chemicals company’s stock valued at $21,816,000 after acquiring an additional 741,846 shares during the last quarter. Institutional investors own 94.50% of the company’s stock.

The stock’s 50-day moving average is $10.65. The stock has a market capitalization of $3.16 billion, a PE ratio of 12.70, a P/E/G ratio of 4.42 and a beta of 2.59. The company has a debt-to-equity ratio of 2.55, a current ratio of 2.19 and a quick ratio of 2.00. Platform Specialty Products Corp has a twelve month low of $9.09 and a twelve month high of $13.54.

Platform Specialty Products Company Profile

Platform Specialty Products Corp. engages in the provision of technology chemical products and technical services. It operates its business through the Performance Solutions and Agricultural Solutions segments. The Performance Solutions segment formulates and markets chemistry solutions that are used in production, commercial packaging and printing, electronics, and oil and gas production and drilling.

Recommended Story: Understanding Compound Annual Growth Rate (CAGR)

Institutional Ownership by Quarter for Platform Specialty Products (NYSE:PAH)

Receive News & Ratings for Platform Specialty Products Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Platform Specialty Products and related companies with MarketBeat.com's FREE daily email newsletter.